Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA9 | Q16790 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | KAT6A | Q92794 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | AGER | Q15109 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25283799 | 0.82 | CA12 (0.56) | CA12CA1CA9CA2CA7 | |
| Fluoride SCHEMBL25237517 | 0.80 | CA12 (0.57) | CA12CA1CA9CA2CA7 | |
| 1,4-Diallyloxybenzene SCHEMBL302448 | 0.79 | CA12 (0.63) | CA12CA1CA9CA2CA7 | |
| SCHEMBL18329363 | 0.78 | CA2 (0.41) | CA12CA1CA9CA2CA7 | |
| SCHEMBL536507 | 0.77 | CA12 (0.73) | CA12CA1CA9CA2CA7 | |
| SCHEMBL17318128 | 0.77 | CA2 (0.52) | CA1CA9CA2 | |
| SCHEMBL398360 | 0.74 | CA1 (1.00) | CA12CA1CA9CA2CA7 | |
| SCHEMBL4813146 | 0.74 | CA12 (0.69) | CA12CA1CA9CA2CA7 | |
| SCHEMBL8989972 | 0.74 | CA12 (0.69) | CA12CA1CA9CA2CA7 | |
| SCHEMBL3725957 | 0.74 | CA12 (0.69) | CA12CA1CA9CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116417664-A | Electrolyte solution for lithium secondary battery and lithium secondary battery comprising the same | 现代自动车株式会社 | 2023-07-11 | — | — | CN | claimed |
| CN-116417664-A | Electrolyte solution for lithium secondary battery and lithium secondary battery comprising the same | 现代自动车株式会社 | 2023-07-11 | — | — | CN | disclosed |
| US-20230207875-A1 | ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME | KIA MOTORS CORPORATION (KR) | 2023-06-29 | — | — | US | disclosed |
| US-20230207875-A1 | ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME | KIA MOTORS CORPORATION (KR) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230207875-A1 | ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME | LDHB, SOD1, CACNA1F | CA12 325/4885CA1 291/4885CA9 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.